X0202 SCHEDULE 13G/A 0001646799 XXXXXXXX LIVE 1 Common Stock, par value $0.001 per share 06/30/2026 0001621221 Artelo Biosciences, Inc. 04301G706 505 Lomas Santa Fe Suite 160 Solana Beach CA 92075 Rule 13d-1(c) Mitchell P. Kopin X1 0.00 173914.00 0.00 173914.00 173914.00 N 4.8 HC IN Daniel B. Asher X1 0.00 173914.00 0.00 173914.00 173914.00 N 4.8 HC IN Intracoastal Capital LLC DE 0.00 173914.00 0.00 173914.00 173914.00 N 4.8 OO Artelo Biosciences, Inc. 505 Lomas Santa Fe, Suite 160, Solana Beach, CA 92075 This Schedule 13G is being filed on behalf of (i) Mitchell P. Kopin, an individual ("Mr. Kopin"), (ii) Daniel B. Asher, an individual ("Mr. Asher") and (iii) Intracoastal Capital LLC, a Delaware limited liability company ("Intracoastal" and together with Mr. Kopin and Mr. Asher, collectively the "Reporting Persons"). The principal business office of Mr. Kopin and Intracoastal is 245 Palm Trail, Delray Beach, Florida 33483. The principal business office of Mr. Asher is 1011 Lake Street, Suite 311, Oak Park, Illinois 60301. Mr. Kopin is a citizen of the United States of America. Mr. Asher is a citizen of the United States of America. Intracoastal is a Delaware limited liability company. Y As of the close of business on June 30, 2026, each of the Reporting Persons may have been deemed to have beneficial ownership of 173,914 shares of Common Stock issuable upon exercise of a warrant held by Intracoastal (the "Intracoastal Warrant"), and all such shares of Common Stock represent beneficial ownership of approximately 4.8% of the Common Stock, based on (1) 3,485,540 shares of Common Stock outstanding as of May 26, 2026, as reported to the Reporting Persons by the Issuer and (2) 173,914 shares of Common Stock issuable upon exercise of the Intracoastal Warrant. 4.8% 0 173,914 0 173,914 N Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. Mitchell P. Kopin /s/ Mitchell P. Kopin 08/13/2026 Daniel B. Asher /s/ Daniel B. Asher 08/13/2026 Intracoastal Capital LLC /s/ Mitchell P. Kopin 08/13/2026